Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 11 results found. Search for [ pfizer earning ]

Results 1 to 11 of 11
BusinessToday.In
March 11, 2021
Canada got the first consignment of Covishield from India last week; India will send another consignment of 1.5 million doses to Canada


Rashi Bisaria
New Delhi, February 6, 2021
Covid-19 vaccine: AstraZeneca applies for approval in JapanDrugmaker AstraZeneca PLC said on Friday it had applied for approval in Japan of its COVID-19 vaccine, making it the second pharmaceutical firm to do so after Pfizer Inc. The Japanese government in December signed a contract to procure 120 million doses of the AstraZeneca vaccine, enough for 60 million people. Aviation sector showing positive signs but still in eye of storm: Airbus India presidentThe Indian aviation sector is showi...


BusinessToday.In
February 3, 2021
In releasing its fourth-quarter earnings, Pfizer also forecast 2021 sales between $59.4 billion and $61.4 billion. The company raised its full-year earnings guidance to between $3.10 to $3.20 from $3 to $ 3.10 earlier


Nidhi Singal
November 18, 2020
According to Apple, this new developer programme will accelerate innovation and help small businesses and independent developers propel their businesses forward by publishing apps on the App Store


BusinessToday.In
August 30, 2020
The reason why Exxon's stock has plunged is for more than the simple fact that oil has fallen out of favour by investors


BusinessToday.In
June 16, 2020
CSB Bank stock trades higher than 5, 20, 50 and 100-day but lower than 200-day moving averages. The stock has grown 15.34% in one week and 29,27% in one month


PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


By Joe C. Mathew
Delhi, October 5, 2016
One of the earliest diagnoses made by Sun Pharma in the run-up to the Ranbaxy acquisition was that since the entire management was focusing on resolving the US FDA's negative observations, there was a lack of focus towards expanding the business.


Chitra Narayanan with Jyotindra Dubey
July 29, 2015
Corner-office salaries are moving northwards even as junior and mid-level pay remains stagnant, widening the compensation divide among ranks.


Dipak Mondal/Money Today
Delhi, August 29, 2011
Here are some mid-cap stocks that have the potential to grow into large companies in the next 5-10 years. Hold on to them for the long term.


Rahul Oberoi/Money Today
Delhi, August 25, 2011
Equities that you should aim to have in your portfolio.


PAGES 1 OF 1